The Doctor Shortage Is Getting Worse. Your Pharmacist Can Help.

The physician shortage is real and worsening. Trusted and accessible pharmacists can help, and looking for business model to support the investment.

Alignment Healthcare CEO Adds Chairman Role As Medicare Business Grows

Alignment Healthcare is bolstering its C-suite, adding the chairman’s role to CEO John Kao’s duties while promoting executives as the provider of Medicare Advantage grows.

Health Insurers Performing Better But There’s Potential Trouble Ahead

Health insurance companies including UnitedHealthcare, CVS Health’s Aetna and Blue Cross and Blue Shield plans are seeing lower costs. But there’s trouble ahead.

Oscar Health Reports Record Profit As Obamacare Enrollment Jumps

Oscar Health swung to a $679 million first quarter profit – the highest in company history – as its health plan membership jumped more than 50% and medical costs eased.

Alignment Healthcare Turns A Profit As Medicare Advantage Costs Ease

Alignment Healthcare reported net income$11 million as costs of care for older adults in its Medicare Advantage plans eased amid industry struggles with medical expenses.

Cigna Plans To Exit Obamacare In 2027 Affecting 369,000 With Coverage

Cigna will exit the individual health insurance business also known as Obamacare, leaving about 369,00 health plan members in 11 states looking for new coverage in 2027.

Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly

Humana reported first quarter net income of nearly $1.2 billion as costs of care for older adults in its Medicare Advantage plans eased a bit but remained high.

Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies

Health insurer Centene reported first quarter net income of $1.5 billion despite a 2 million enrollee drop in Obamacare enrollment.

Mark Cuban’s Cost Plus Drugs, Humana In Deal To Take On Employer Drug Costs

Mark Cuban’s Cost Plus Drug Company and Humana’s CenterWell Pharmacy confirmed they have formed a partnership “to develop new end-to-end employer prescription solutions.”

Cell, Gene And Specialty Drug Costs Intensify For Health Plans

Specialty drugs are an increasing worry for health plans and employers as new and innovative therapies enter the U.S. market and patients flock to them.